Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.05 per share
-
Shares outstanding
-
95,490,450
-
Total 13F shares
-
13,602,212
-
Share change
-
+827,261
-
Total reported value
-
$16,864,343
-
Price per share
-
$1.24
-
Number of holders
-
27
-
Value change
-
-$51,496
-
Number of buys
-
8
-
Number of sells
-
13
Institutional Holders of Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) as of Q1 2025
As of 31 Mar 2025,
Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,602,212 shares.
The largest 10 holders included
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC, Long Focus Capital Management, LLC, B Group, Inc., MACQUARIE GROUP LTD, BAILLIE GIFFORD & CO, MILLENNIUM MANAGEMENT LLC, MORGAN STANLEY, LPL Financial LLC, ACADIAN ASSET MANAGEMENT LLC, and UBS Group AG.
This page lists
27
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.